Safety Study of Chimeric Vaccine to Prevent ETEC Diarrhea
A Phase 1 Dose Escalating Study of Two Enterotoxigenic Escherichia Coli Prototype Adhesin-based Vaccines With or Without Modified Heat-labile Enterotoxin by Intradermal or Transcutaneous Immunization
Sponsor: U.S. Army Medical Research and Development Command
A PHASE1 clinical study on Escherichia Coli Infection, this trial is completed. The trial is conducted by U.S. Army Medical Research and Development Command and has accumulated 10 data snapshots since 2012. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Mar 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Mar 2021 [monthly]
Completed PHASE1
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE1
▶ Show 5 earlier versions
-
Aug 2019 — Sep 2020 [monthly]
Completed PHASE1
Status: Unknown Status → Completed
-
Jun 2018 — Aug 2019 [monthly]
Unknown Status PHASE1
-
Feb 2018 — Jun 2018 [monthly]
Unknown Status PHASE1
Status: Active Not Recruiting → Unknown Status
-
Feb 2017 — Feb 2018 [monthly]
Active Not Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE1
First recorded
Aug 2012
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- U.S. Army Medical Research and Development Command
For direct contact, visit the study record on ClinicalTrials.gov .